Home > Qtrly Results > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Quarterly Results Analysis [Dec2025]

EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹2,363 Cr ₹2,270 Cr ₹2,101 Cr ₹2,116 Cr ₹1,963 Cr ₹2,002 Cr ₹1,815 Cr ₹1,771 Cr
Expenses ₹1,871 Cr ₹1,831 Cr ₹1,684 Cr ₹1,714 Cr ₹1,608 Cr ₹1,621 Cr ₹1,478 Cr ₹1,461 Cr
Operating Income ₹493 Cr ₹439 Cr ₹417 Cr ₹402 Cr ₹355 Cr ₹381 Cr ₹337 Cr ₹311 Cr
Other Income ₹2 Cr ₹39 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹36 Cr ₹23 Cr ₹12 Cr
Interest ₹38 Cr ₹33 Cr ₹27 Cr ₹39 Cr ₹32 Cr ₹46 Cr ₹59 Cr ₹65 Cr
Depreciation ₹105 Cr ₹105 Cr ₹99 Cr ₹97 Cr ₹97 Cr ₹97 Cr ₹94 Cr ₹91 Cr
Profit Before Tax ₹314 Cr ₹341 Cr ₹291 Cr ₹261 Cr ₹230 Cr ₹273 Cr ₹207 Cr ₹167 Cr
Profit After Tax ₹231 Cr ₹251 Cr ₹215 Cr ₹197 Cr ₹156 Cr ₹202 Cr ₹153 Cr ₹121 Cr
EPS ₹12.16 ₹12.84 ₹10.92 ₹9.97 ₹8.11 ₹10.29 ₹7.95 ₹6.36
Industry Peers & Returns1W1M1Y
EMCURE PHARMACEUTICALS 0.2% -4.9% 37%
SUN PHARMACEUTICAL INDUSTRIES 0.6% 7% 1.4%
DIVIS LABORATORIES 1.6% 4.6% 3.7%
CIPLA 1.5% -2.1% -7.3%
TORRENT PHARMACEUTICALS 3.1% 5.9% 39%
DR REDDYS LABORATORIES 0.5% 9.8% 5.7%
MANKIND PHARMA -0.2% -2.3% -14.8%
ZYDUS LIFESCIENCES -1.2% 4.3% -2.9%
LUPIN 0.7% 2.8% 11%

EMCURE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

4.13 %

Y-o-Y

20.42 %

Quarters Revenues % Change
Dec2025 ₹2,363 Cr
4.13
Sep2025 ₹2,270 Cr
8.06
Jun2025 ₹2,101 Cr
-0.74
Mar2025 ₹2,116 Cr
7.83
Dec2024 ₹1,963 Cr
-1.97
Sep2024 ₹2,002 Cr
10.29
Jun2024 ₹1,815 Cr
2.47
Mar2024 ₹1,771 Cr -

EMCURE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

12.21 %

Y-o-Y

38.95 %

Quarters Operating Profit % Change
Dec2025 ₹493 Cr
12.21
Sep2025 ₹439 Cr
5.36
Jun2025 ₹417 Cr
3.57
Mar2025 ₹402 Cr
13.48
Dec2024 ₹355 Cr
-6.85
Sep2024 ₹381 Cr
13.08
Jun2024 ₹337 Cr
8.37
Mar2024 ₹311 Cr -
Operating Margins
Q-o-Q

7.75 %

Y-o-Y

15.38 %

Quarters Operating Margin% % Change
Dec2025 20.85%
7.75
Sep2025 19.35%
-2.47
Jun2025 19.84%
4.37
Mar2025 19.01%
5.20
Dec2024 18.07%
-4.99
Sep2024 19.02%
2.53
Jun2024 18.55%
5.76
Mar2024 17.54% -

EMCURE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-7.96 %

Y-o-Y

48.23 %

Quarters Profit After Tax % Change
Dec2025 ₹231 Cr
-7.96
Sep2025 ₹251 Cr
17.03
Jun2025 ₹215 Cr
8.90
Mar2025 ₹197 Cr
26.36
Dec2024 ₹156 Cr
-22.55
Sep2024 ₹202 Cr
32.09
Jun2024 ₹153 Cr
26.09
Mar2024 ₹121 Cr -
PAT Margins
Q-o-Q

-11.56 %

Y-o-Y

23.14 %

Quarters PAT Margin(%) % Change
Dec2025 9.79 %
-11.56
Sep2025 11.07 %
8.21
Jun2025 10.23 %
9.76
Mar2025 9.32 %
17.23
Dec2024 7.95 %
-21.05
Sep2024 10.07 %
19.74
Jun2024 8.41 %
23.13
Mar2024 6.83 % -

EMCURE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-5.30 %

Y-o-Y

49.94 %

Quarters EPS % Change
Dec2025 ₹12.16
-5.30
Sep2025 ₹12.84
17.58
Jun2025 ₹10.92
9.53
Mar2025 ₹9.97
22.93
Dec2024 ₹8.11
-21.19
Sep2024 ₹10.29
29.43
Jun2024 ₹7.95
25.00
Mar2024 ₹6.36 -

You may also like the below Video Courses